Sullivan R, Yau WY, O’Connor E, Houlden H. Spinocerebellar ataxia: an update. J Neurol [Internet]. 2019;266:533–44. http://link.springer.com/https://doi.org/10.1007/s00415-018-9076-4.

Article  PubMed  Google Scholar 

Ashizawa T, Öz G, Paulson HL. Spinocerebellar ataxias: prospects and challenges for therapy development [Internet]. Nat. Rev. Neurol. Nat Rev Neurol; 2018 [cited 2024 Feb 8]: [590–605 p.]. Available from: https://pubmed.ncbi.nlm.nih.gov/30131520/

Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Prim [Internet]. 2019;5:24. Available from: https://www.nature.com/articles/s41572-019-0074-3

Article  PubMed  Google Scholar 

Almeida-Silva UC, Hallak JEC, Júnior WM, de Osório F. L. Association between spinocerebellar ataxias caused by glutamine expansion and psychiatric and neuropsychological signals - a literature review. Am J Neurodegener Dis [Internet]. 2013 [cited 2024 Feb 8]; 2:57 . Available from: /pmc/articles/PMC3703120/

Schmitz-Hübsch T, Du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C et al. Scale for the assessment and rating of ataxia: Development of a new clinical scale. Neurology [Internet]. 2006 [cited 2024 Feb 29];66:1717–20. Available from: https://pubmed.ncbi.nlm.nih.gov/16769946/

Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K et al. International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci [Internet]. 1997 [cited 2024 Feb 29];145:205–11. Available from: https://pubmed.ncbi.nlm.nih.gov/9094050/

Paulson HL, Shakkottai VG, Clark HB, Orr HT. Polyglutamine spinocerebellar ataxias-from genes to potential treatments [Internet]. Nat. Rev. Neurosci. Nat Rev Neurosci; 2017 [cited 2024 Feb 8]: [613–26]. Available from: https://pubmed.ncbi.nlm.nih.gov/28855740/

Buijsen RAM, Toonen LJA, Gardiner SL, van Roon-Mom WMC. Genetics, Mechanisms, and therapeutic progress in polyglutamine spinocerebellar ataxias [Internet]. Neurotherapeutics Neurotherapeutics; 2019. p. 263–86. Available from: https://pubmed.ncbi.nlm.nih.gov/30607747/

Manto MU. The wide spectrum of spinocerebellar ataxias (SCAs) [Internet]. Cerebellum. Cerebellum; 2005 [cited 2024 Feb 8]: [2–6 p.]. Available from: https://pubmed.ncbi.nlm.nih.gov/15895552/

Ruano L, Melo C, Silva MC, Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia: A systematic review of prevalence studies [Internet]. Neuroepidemiology. Neuroepidemiology; 2014 [cited 2024 Feb 8]: [174–83 p.]. Available from: https://pubmed.ncbi.nlm.nih.gov/24603320/

Sánchez-López CR, Perestelo-Pérez L, Escobar A, López-Bastida J, Serrano-Aguilar P. Health-related quality of life in patients with spinocerebellar ataxia. Neurol (English Ed [Internet]. 2017;32:143–51. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2173580816301365

Diallo A, Jacobi H, Cook A, Labrum R, Durr A, Brice A et al. Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study. Lancet Neurol [Internet]. 2018 [cited 2024 Feb 8];17:327–34. Available from: https://pubmed.ncbi.nlm.nih.gov/29553382/

Klockgether T, Lüdtke R, Kramer B, Abele M, Bürk K, Schöls L et al. The natural history of degenerative ataxia: A retrospective study in 466 patients. Brain [Internet]. 1998 [cited 2024 Feb 8];121:589–600. Available from: https://pubmed.ncbi.nlm.nih.gov/9577387/

Bhandari J, Thada PK, Samanta D. Spinocerebellar Ataxia. StatPearls [Internet]. 2023 [cited 2024 Feb 13]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557816/

Rodríguez-Díaz JC, Velázquez-Pérez L, Rodríguez Labrada R, Aguilera Rodríguez R, Laffita Pérez D, Canales Ochoa N et al. Neurorehabilitation therapy in spinocerebellar ataxia type 2: A 24-week, rater-blinded, randomized, controlled trial. Mov Disord [Internet]. 2018 [cited 2024 Feb 13];33:1481–7. Available from: https://pubmed.ncbi.nlm.nih.gov/30132999/

Synofzik M, Ilg W. Motor training in degenerative spinocerebellar disease: Ataxia-specific improvements by intensive physiotherapy and exergames [Internet]. Biomed Res. Int. Biomed Res Int; 2014 [cited 2024 Feb 13]. Available from: https://pubmed.ncbi.nlm.nih.gov/24877117/

Ghanekar SD, Kuo S-H, Staffetti JS, Zesiewicz TA. Current and emerging treatment modalities for spinocerebellar ataxias. Expert Rev Neurother [Internet]. 2022;22:101–14. Available from: https://www.tandfonline.com/doi/full/https://doi.org/10.1080/14737175.2022.2029703

Benussi A, Pascual-Leone A, Borroni B. Non-invasive cerebellar stimulation in neurodegenerative ataxia: a literature review. Int J Mol Sci. 2020;21(6):1948. https://doi.org/10.3390/ijms21061948.

Article  PubMed  PubMed Central  Google Scholar 

Grimaldi G, Argyropoulos GP, Boehringer A, Celnik P, Edwards MJ, Ferrucci R et al. Non-invasive cerebellar stimulation - a consensus paper [Internet]. Cerebellum. Cerebellum; 2014 [cited 2024 Feb 13]: [121–38 p.] . Available from: https://pubmed.ncbi.nlm.nih.gov/23943521/

Valls-solé Pascual-leoneA, Wassermann J, Hallett EM. M. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain [Internet]. 1994 [cited 2024 Feb 21];117:847–58. Available from: https://pubmed.ncbi.nlm.nih.gov/7922470/

Shiga Y, Tsuda T, Itoyama Y, Shimizu H, Miyazawa K-II, Jin K et al. Transcranial magnetic stimulation alleviates truncal ataxia in spinocerebellar degeneration. J Neurol Neurosurg Psychiatry [Internet]. 2002 [cited 2024 Jan 25];72:124–6. Available from: https://jnnp.bmj.com/content/72/1/124

Manor B, Greenstein PE, Davila-Perez P, Wakefield S, Zhou J, Pascual-Leone A et al. Repetitive transcranial magnetic stimulation in spinocerebellar ataxia: a pilot randomized controlled trial. Front Neurol [Internet]. 2019 [cited 2024 Jan 25];10:73. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30809184

França C, de Andrade DC, Silva V, Galhardoni R, Barbosa ER, Teixeira MJ et al. Effects of cerebellar transcranial magnetic stimulation on ataxias: a randomized trial. Park Relat Disord [Internet]. 2020 [cited 2024 Jan 25];80:1–6. Available from: http://www.prd-journal.com/article/S135380202030715X/fulltext

Lefaucheur JP, André-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin. Neurophysiol. Elsevier; 2014. p. 2150–206.

Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ WV, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.2. Handbook [Internet]. 2021; Available from: www.training.cochrane.org/handbook

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ [Internet]. 2021;372:n71. Available from: https://www.bmj.com/lookup/doi/https://doi.org/10.1136/bmj.n71

Handbook GH, October U, Sch H, Bro J, Guyatt G, Oxman A et al. GRADE Handbook. 2015 [cited 2021 Oct 13]: [1–57 p.]. Available from: https://gdt.gradepro.org/app/handbook/handbook.html#h.svwngs6pm0f2

Ankit Rohatgi (Automeris LLC). AI assisted data extraction from charts using WebPlotDigitizer [Internet]. 2024 [cited 2024 Jul 3]. Available from: https://automeris.io/

Higgins JPT, Savović J, Page MJ, Elbers RGSJ. Chapter 8: assessing risk of bias in a randomized trial | Cochrane training [Internet]. Cochrane Handb. Syst. Rev. Interv. version 6.0 (updated July 2019). 2019. Available from: https://training.cochrane.org/handbook/current/chapter-08

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ [Internet]. 2019;l4898. Available from: https://www.bmj.com/lookup/doi/https://doi.org/10.1136/bmj.l4898

McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and shiny web app for visualizing risk-of-bias assessments. Res Synth Methods [Internet]. 2021;12:55–61. Available from: https://onlinelibrary.wiley.com/doi/https://doi.org/10.1002/jrsm.1411

Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol [Internet]. 2014 [cited 2021 Jun 23]: [14 p.]. Available from: https://pubmed.ncbi.nlm.nih.gov/25524443/

Schmitz-Hübsch T, Fimmers R, Rakowicz M, Rola R, Zdzienicka E, Fancellu R, et al. Responsiveness of different rating instruments in spinocerebellar ataxia patients. Neurology. 2010;74:678–84.

Article  PubMed  Google Scholar 

Reoli R, Therrien A, Cherry-Allen K, Keller J, Millar J, Bastian A. Is the dynamic gait index a useful outcome to measure balance and ambulation in patients with cerebellar ataxia? Gait Posture. 2021;89:200–5.

Article  PubMed  PubMed Central  Google Scholar 

Schünemann H, Brożek J, Guyatt G, Oxman AE. GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group, 2013. GRADE Work Gr [Internet]. 2013. Available from: https://www.guidelinedevelopment.org/handbook

Sikandar A, Liu X-HH, Xu H-LL, Li Y, Lin Y-QQ, Chen X-YY et al. Short-term efficacy of repetitive transcranial magnetic stimulation in SCA3: A prospective, randomized, double-blind, sham-controlled study. Parkinsonism Relat Disord [Internet]. 2023 [cited 2024 Jan 25];106:105236. Available from: http://ovidsp.ovid.com/ovidweb.cgi?T=JS%26;PAGE=reference%26;D=med23%26;NEWS=N%26;AN=36529111

Liu X, Zhang L, Xu H-L, Liu X-H, Sikandar A, Li M-C et al. Effect of regional brain activity following repeat transcranial magnetic stimulation in SCA3: a secondary analysis of a randomized clinical trial. cerebellum [Internet]. 2024; Available from: https://www.embase.com/search/results?subaction=viewrecord%26;id=L2029247721%26;from=export

Zhou M, Qiu M, Jin Y, Li D, Tao C, Lou D et al. Effectiveness of high-frequency repetitive transcranial magnetic stimulation in patients with spinocerebellar ataxia type 3. J ECT [Internet]. 2024;Publish Ah:15–9. Available from: https://journals.lww.com/https://doi.org/10.1097/YCT.0000000000000925

Shi Y, Zou G, Chen Z, Wan L, Peng L, Peng H et al. Efficacy of cerebellar transcranial magnetic stimulation in spinocerebellar ataxia type 3: a randomized, single-blinded, controlled trial. J Neurol [Internet]. 2023 [cited 2024 Jan 25];270:5372–9. Available from: https://pubmed.ncbi.nlm.nih.gov/37433893/

Sanna A, Follesa P, Tacconi P, Serra M, Pisu MG, Cocco V et al. therapeutic use of cerebellar intermittent theta burst stimulation (iTBS) in a sardinian family affected by spinocerebellar ataxia 38 (SCA 38). Cerebellum [Internet]. 2022 [cited 2024 Feb 21];21:623–31. Available from: https://pubmed.ncbi.nlm.nih.gov/34410614/

Chen X, Liu X, Sikandar A,Li M, Chen Q,Gan S, LY, Chen XY, Lian YH, Liu XH, Sikandar A, Li MC et al. Effects of repetitive transcranial magnetic stimulation on cerebellar metabolism in patients with spinocerebellar ataxia type 3. Front Aging Neurosci [Internet]. 2022 [cited 2024 Jan 25];14:827993. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082263

França C, Silva V, Galhardoni R, Barbosa ER,Teixeira MJ,Cury RG, ADc, França C, de Andrade DC, Silva VV, Galhardoni R, Barbosa ER et al. Effects of cerebellar transcranial magnetic stimulation on ataxias: a randomized trial. Park Relat Disord [Internet]. 2020 [cited 2024 Jan 25];80:1–6. Available from: http://ovidsp.ovid.com/ovidweb.cgi?T=JS%26;PAGE=reference%26;D=med18%26;NEWS=N%26;AN=32920321

Fei-fei Hua-anWFLJBDY, Li-jun W, Jing Z, Bing-qian W, Dan-dan F. S YPE. Efficacy of high-frequency repetitive transcranial magnetic stimulation on motor symptoms in patients with Spinocerebellar ataxia 3(SCA3) - CNKI. Chin Manip Rehabilit Med [Internet]. 2018 [cited 2024 Jan 25];9:14–5. Available from: http://kns.cnki.net/kcms/detail/detail.aspx?doi=10.19787/j.issn.1008-1879.2018.16.007

Qianhui. The efficacy of repetitive transcranial magnetic stimulation in the treatment of spinocerebellar ataxia. 杭州师范大学; 2020.

Gong C, Long Y, Peng XM, Hu H, Chen J, Xiao L et al. Efficacy and safety of noninvasive brain stimulation for patients with cerebellar ataxia: a systematic review and meta-analysis of randomized controlled trials [Internet]. J. Neurol. J Neurol; 2023 [cited 2024 Feb 15]: [4782–99 p.]. Available from: https://pubmed.ncbi.nlm.nih.gov/37460852/

Yin L, Wang X, Chen L, Liu D, Li H, Liu Z et al. Repetitive transcranial magnetic stimulation for cerebellar ataxia: a systematic review and meta-analysis. Front Neurol [Internet]. 2023 [cited 2024 Mar 20];14:1049813. Available from: https://www.frontiersin.org/articles/10.3389/fneur.2023.1049813/full

Wang Y, Zhang D, Wang J, Ma J, Lu L, Jin S. Effects of transcranial magnetic stimulation on cerebellar ataxia: A systematic review and meta-analysis. Front. Neurol. Frontiers Media S.A.; 2023. p. 1049813.

IntHout J, Ioannidis JPA, Borm GF, Goeman JJ. Small studies are more heterogeneous than large ones: a meta-meta-analysis. J Clin Epidemiol [Internet]. 2015;68:860–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S089543561500164X

Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol [Internet]. 2009;120:2008–39. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1388245709005197

Gan S-R, Figueroa KP, Xu H-L, Perlman S, Wilmot G, Gomez CM et al. The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3. Parkinsonism Relat Disord [Internet]. 2020;72:37–43. Available from: https://linkinghub.elsevier.com/retrieve/pii/S135380202030033X

Peryer G, Golder S, Junqueira D, Vohra SLY. Chapter 19: Adverse effects [last updated October 2019]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handb Syst Rev Interv version 65. 2024.

Schmahmann JD, Pierce S, MacMore J, L’Italien GJ. Development and validation of a patient-reported outcome measure of ataxia. Mov Disord [Internet]. 2021;36:2367–77. Available from: https://movementdisorders.onlinelibrary.wiley.com/doi/https://doi.org/10.1002/mds.28670